Literature DB >> 11552913

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru.

J J Ortiz1, A Ayoub, G Gargala, N L Chegne, L Favennec.   

Abstract

BACKGROUND: Enteric infection by Giardia intestinalis is a common cause of diarrhoea world-wide and a significant cause of morbidity in children. AIM: To compare the efficacy and safety of nitazoxanide and metronidazole in the treatment of diarrhoea caused by G. intestinalis in children.
METHODS: A total of 110 children presenting with diarrhoea caused by G. intestinalis were randomized to treatment with either a 3-day course of nitazoxanide (100 mg b.d., age range 2-3 years; 200 mg b.d., age range 4-11 years) or a 5-day course of metronidazole (125 mg b.d., age range 2-5 years; 250 mg b.d., age range 6-11 years). The patients were followed-up for a determination of clinical response 7 days after the initiation of treatment, and two subsequent stool samples were collected for parasitological examination.
RESULTS: Diarrhoea had resolved in 47 children out of 55 (85%) in the nitazoxanide treatment group before the day 7 follow-up visit, compared to 44 out of 55 (80%) for metronidazole. Diarrhoea resolved within 4 days in most cases. Only mild, transient adverse events were reported.
CONCLUSIONS: A 3-day course of nitazoxanide suspension is as efficacious as a standard 5-day course of metronidazole suspension in treating giardiasis in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552913     DOI: 10.1046/j.1365-2036.2001.01066.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

Review 1.  Current drug therapy of protozoal diarrhoea.

Authors:  Y K Gupta; Madhur Gupta; S Aneja; K Kohli
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

Review 2.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

Review 3.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 4.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

5.  Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.

Authors:  Ana E Gamiño-Arroyo; M Lourdes Guerrero; Sean McCarthy; Alejandra Ramírez-Venegas; Beatriz Llamosas-Gallardo; Arturo Galindo-Fraga; Sarbelio Moreno-Espinosa; Yuri Roldán-Aragón; Javier Araujo-Meléndez; Sally Hunsberger; Violeta Ibarra-González; Julia Martínez-López; Luis A García-Andrade; Heather Kapushoc; H Preston Holley; Mary C Smolskis; Guillermo M Ruiz-Palacios; John H Beigel
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

6.  Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana.

Authors:  A A Escobedo; P Almirall; M Alfonso; Y Salazar; I Avila; S Cimerman; F A Núñez; I V Dawkins
Journal:  Ann Trop Med Parasitol       Date:  2011-01

7.  The principal conductance in Giardia lamblia trophozoites possesses functional properties similar to the mammalian ClC-2 current.

Authors:  Eloy G Moreno-Galindo; Julio C Rodríguez-Elías; Mario A Ramírez-Herrera; José A Sánchez-Chapula; Ricardo A Navarro-Polanco
Journal:  Pflugers Arch       Date:  2013-09-17       Impact factor: 3.657

8.  Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.

Authors:  Yvonne Guttner; Helen M Windsor; Charlie H Viiala; Leon Dusci; Barry J Marshall
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 9.  Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

Authors:  Vanessa R Anderson; Monique P Curran
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  The old and new therapeutic approaches to the treatment of giardiasis: where are we?

Authors:  Haendel G N O Busatti; Joseph F G Santos; Maria A Gomes
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.